MedTrace Logo

A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

NCT07173829 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2025-09-15

No results posted yet for this study

Summary

BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.

Conditions

Interventions

OTHER

samples

A 50 ml blood sample will be taken from the patient before the operation, and two 0.3 cm3 tumor samples will be taken during the operation from the resected tumor.

Sponsors & Collaborators

  • University of Bordeaux

    collaborator OTHER

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Julien ENGELHARDT, Dr · University Hospital, Bordeaux

  • Mathieu LARROQUETTE, Dr · University Hospital, Bordeaux

  • Guillaume CHOTARD, Dr · University Hospital, Bordeaux

  • Lionel COUZI, Pr · Bordeaux university Hospital, Bordeaux University

  • Andreas BIKFALVI, Pr · University of Bordeaux

  • Charles DUPIN, Dr · University Hospital, Bordeaux

  • Véronique VENDRELY, Pr · Bordeaux university Hospital, Bordeaux University

  • Julie DECHANET-MERVILLE, Dr · University of Bordeaux

  • Thomas DAUBON, Dr · University of Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2030-12-31
Completion
2030-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07173829 on ClinicalTrials.gov